CN105254721B - 米卡芬净的纯化转盐方法 - Google Patents
米卡芬净的纯化转盐方法 Download PDFInfo
- Publication number
- CN105254721B CN105254721B CN201410202172.7A CN201410202172A CN105254721B CN 105254721 B CN105254721 B CN 105254721B CN 201410202172 A CN201410202172 A CN 201410202172A CN 105254721 B CN105254721 B CN 105254721B
- Authority
- CN
- China
- Prior art keywords
- mobile phase
- salt
- micafungin
- purification
- column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410202172.7A CN105254721B (zh) | 2014-05-13 | 2014-05-13 | 米卡芬净的纯化转盐方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410202172.7A CN105254721B (zh) | 2014-05-13 | 2014-05-13 | 米卡芬净的纯化转盐方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105254721A CN105254721A (zh) | 2016-01-20 |
CN105254721B true CN105254721B (zh) | 2021-05-18 |
Family
ID=55094698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410202172.7A Active CN105254721B (zh) | 2014-05-13 | 2014-05-13 | 米卡芬净的纯化转盐方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105254721B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788545B (zh) * | 2014-05-29 | 2019-03-01 | 上海天伟生物制药有限公司 | 一种环肽类化合物的结晶粉末及其制备方法和用途 |
CN108250274A (zh) * | 2016-12-28 | 2018-07-06 | 浙江华谱新创科技有限公司 | 米卡芬净高效分离纯化方法 |
CN109956994B (zh) * | 2017-12-25 | 2022-09-30 | 江苏豪森药业集团有限公司 | 米卡芬净钠盐的制备方法 |
CN113087775B (zh) * | 2018-05-31 | 2022-07-08 | 杭州中美华东制药有限公司 | 米卡芬净钠新晶型ii及其制备方法 |
CN114249800A (zh) * | 2020-09-22 | 2022-03-29 | 深圳市星银医药有限公司 | 一种双羟萘酸多肽药物的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102627688A (zh) * | 2012-03-30 | 2012-08-08 | 上海天伟生物制药有限公司 | 一种高纯度环肽化合物及其制备方法和用途 |
CN103483427A (zh) * | 2012-06-09 | 2014-01-01 | 浙江海正药业股份有限公司 | 一种棘白菌素类化合物的纯化方法 |
CN103533995A (zh) * | 2011-04-20 | 2014-01-22 | 赛利亚医药公司 | 提纯米卡芬净的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106397543A (zh) * | 2010-09-28 | 2017-02-15 | 中化帝斯曼制药有限公司荷兰公司 | 用于分离环六肽的方法 |
CN102952178B (zh) * | 2011-08-24 | 2016-04-27 | 华北制药集团新药研究开发有限责任公司 | 一种高纯度棘白霉素类化合物的制备方法 |
-
2014
- 2014-05-13 CN CN201410202172.7A patent/CN105254721B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103533995A (zh) * | 2011-04-20 | 2014-01-22 | 赛利亚医药公司 | 提纯米卡芬净的方法 |
CN102627688A (zh) * | 2012-03-30 | 2012-08-08 | 上海天伟生物制药有限公司 | 一种高纯度环肽化合物及其制备方法和用途 |
CN103483427A (zh) * | 2012-06-09 | 2014-01-01 | 浙江海正药业股份有限公司 | 一种棘白菌素类化合物的纯化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105254721A (zh) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105254721B (zh) | 米卡芬净的纯化转盐方法 | |
EP3064214B1 (en) | Separation and purification method for vancomycin hydrochloride of high purity | |
WO2014125501A1 (en) | An improved process for preparation of sugammadex sodium | |
CN105753867B (zh) | 一种改进的阿维巴坦钠中间体化合物的制备方法 | |
CA2796488C (en) | Purification method of azacyclohexapeptide or its salt | |
CN102276611A (zh) | 一种替比培南酯的重结晶精制方法 | |
CA3162578C (en) | Method for preparing isavuconazonium sulfate | |
CN106749258B (zh) | 一种厄他培南钠的纯化方法 | |
CN104592081B (zh) | 一种氨曲南主环的合成方法 | |
CN110256434B (zh) | 一种制备高纯度二羟丙茶碱的方法 | |
CN112279846B (zh) | 一种制备抗真菌药硫酸艾沙康唑鎓的方法 | |
CN108822014B (zh) | 一种阿维巴坦中间体的合成方法 | |
US20170275335A1 (en) | Improved process for preparation of amorphous linaclotide | |
CN112079819B (zh) | 一种改进的伏立康唑消旋体制备方法 | |
CN110590618A (zh) | 一种阿维巴坦中间体的制备方法 | |
CN105153201B (zh) | 一种盐酸头孢唑兰的制备方法 | |
CN111116503A (zh) | 一种高纯度米卡芬净中间体的制备方法 | |
CN105001114A (zh) | 制备碘普罗胺的新方法 | |
CN112279895A (zh) | 一种化学合成酸性多肽的制备方法 | |
CN103059027A (zh) | 替比培南匹伏酯的制备方法 | |
CN111196862A (zh) | 一种舒更葡糖钠的精制方法 | |
CN111978185B (zh) | 一种水杨胺醋酸盐的制备方法 | |
CN108640912A (zh) | 一种匹多莫德的工业化规模制备方法 | |
CN104230984B (zh) | 一种三水合3‑氨基丙基胺乙基硫代磷酸的制备方法 | |
CN110903346B (zh) | 一种制备盐酸万古霉素杂质ImpC的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160324 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |